The 'new' Organon springs to life after MSD spinout

"I think first and foremost, the most exciting part is the ability to build a women's health-focused company and to be the only one doing it, to be the most focused company on women's health, which is an area that it is about time," Organon managing director Nirelle Tolstoshev told BioPharmaDispatch. …